RVMD - Revolution Medicines Market Value

Graphic logo of RevMed (RVMD)

The Revolution Medicines (RVMD) share price visualized below on the GURU.Markets platform stands at 37.28, with the company's success depending on clinical trial outcomes and the management of development costs. The business relies on creating unique targeted therapies against complex mutations, establishing a foundation of irreplaceable treatment options. Leadership in precision oncology and robust R&D investments confirm its status as a technological innovator.

revmed.com - RVMD Market Capitalization (period 07/04/2022 - 11/15/2026)

Metric breakdowns and analytics for revmed.com (RVMD)

- stock price and consensus target price:
Fundamental company valuation:Revolution Medicines Corp RVMD
Product sample of Revolution Medicines

The market capitalization of Revolution Medicines (RVMD) reflects the aggregate value of all outstanding shares, serving as a gauge of the company's market standing amidst a fierce scientific race for leadership in oncology. By analyzing the issuer's capitalization, an investor assesses the total business value excluding debt, which allows for the determination of the asset's fair price based on expectations of future clinical breakthroughs and patents.

Competitors of Revolution Medicines (RVMD)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|AAPG - Market Value|Market Value cgoncology.com|UroGen (URGN) - Market Value|Market Capitalization BCAX|PSNL (Personalis Genomics) - Market Capitalization|Market Valuation Erasca Corp (ERAS)|Market Capitalization DCTH|Market Capitalization ymabs.com (YMAB)|Market Value Aura Bio AURA|CADL: Market Capitalization|Accuray, Inc. - Market Capitalization|Market Value SELLAS Life Sciences Group|ACTU: Market Capitalization|Market Value citiusonc.com (CTOR)|Market Value tuhurabio.com|TARA: Market Value|Market Valuation FATE (Fate Therapeutics Corp)|WHWK (Aadi Bioscience) - Market Value|Market Capitalization TCRX (TScan Therapeutics)|CSBR - Market Valuation|XBIT: Market Valuation|Market Value CVM (cel-sci.com)|OS Therapies Inc (OSTX) - Market Value|Radiopharm Theranostics - Market Value|ARTV (Artiva Biotherapeutics Inc.) - Market Capitalization|Market Capitalization Adlai Nortye Ltd.|Market Valuation VERU (Veru)|Market Value TPST|Market Value Xilio XLO|Renovaro Inc. (RENB) - Market Value|MURA - Market Value|Market Capitalization Kairos Pharma KAPA|OKUR (OnKure Therapeutics) - Market Valuation|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group